Little pill means big news in the treatment of MS

Links shared publicly online about this topic.

1,440
total visits

Little pill means big news in the treatment of MS

A new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers at Queen Mary, University of London. A major trial of the oral drug Cladribine -- results of which are published in the NEJM on Jan. 20, 2010 -- has shown that it significantly reduces relapse and deterioration of the disease, and goes a long way to eliminating the unpleasant side effects associated with existing therapies.

View full resource at eurekalert.org

Tags: Multiple Sclerosis, Disease and Condition, Drug